This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.
Campylobacteriosis is a very common gastrointestinal disease in the EU/EEA. In 2016, 29 EU/EEA countries reported 248 752 confirmed cases of campylobacteriosis.
Cases of salmonellosis and campylobacteriosis have remained stable over the past five years, although listeriosis is on the rise. In 2017, there was an average of 100 food- and waterborne outbreaks per week.
The seroincidence calculator utilises the combination of serum antibody levels (lgG, lgM, and lgA) at a given point in time to estimate the time since seroconversion, which in turn gives an estimate of annual 'force of infection' in the tested population.
This report is based on data for 2016 retrieved from The European Surveillance System (TESSy) on 26 April 2018. TESSy is a system for the collection, analysis and dissemination of data on communicable diseases. EU Member States and EEA countries contribute to the system by uploading their infectious disease surveillance data at regular intervals.
This report provides a comprehensive update of the epidemiology of pneumonia, bloodstream infections and urinary tract infections European ICUs as well as important reference data for European ICUs performing surveillance of ICU-acquired infections.
This report covers data on antimicrobial resistance in zoonotic and indicator bacteria in 2016, submitted by 28 EU Member States. Resistance in bacterial isolates of zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as in meticillin-resistant Staphylococcus aureus from animals and food were addressed and analysed jointly by ECDC and EFSA.